testosterone propionate half life

admin   08/17/2016   Comments Off on testosterone propionate half life

The main advantages of Biprola:

  • is effective for patients with any degree of testosterone propionate half life
  • controls the level in the AH for 24 hours (reduces the risk of strokes and heart attacks)
  • It can be used in patients with concomitant diseases (highly beat1-blocker)
    • broncho-pulmonary pathology,
    • atherosclerosis of the lower limbs,
    • diabetes,
    • dyslipidemia
  • suitable for receiving and operating elderly patients (1 per day)
  • available for long-term treatment to all categories of the population (competitive price and availability in the city pharmacies)

Biprol has complex medical effects:

  • The hypotensive effect associated with a decrease in cardiac output, peripheral vascular sympathetic stimulation, decreased activity of the renin-angiotensin system and the central nervous system vlieniem
  • The antiarrhythmic effect is due to the elimination of arrhythmogenic factors (tachycardia, increased activity of the sympathetic nervous system, increased cAMP levels, testosterone propionate half life), decrease in the rate of spontaneous excitation of the sinus and ectopic pacemakers and slowing of atrioventricular conduction
  • Antianginal effect is due to a decrease in myocardial oxygen demand as a result of deceleration in heart rate and decrease contractility, lengthening of diastole, improving myocardial perfusion

Features product Biprol:

  • highly selective beta1-blocker (decrease catecholamines stimulate the formation of cAMP from ATP)
  • reducing myocardial oxygen demand
  • It reduces the heart rate (at rest and during exercise)
  • inhibits the conductivity and excitability
  • reduces myocardial contractility
  • no effect on carbohydrate metabolism
  • It does not have membrane-stabilizing effect
  • reduces plasma renin activity
  • without its own sympathomimetic activity
  • reduces intracellular Ca current
  • has a negative chrono, ino, Drome, batrotropnoe action

Biprol available for long-term therapy for patients with co-morbidities

  • with lower extremities atherosclerosis (at doses up to 200 mg is highly selective beta1-blocker)
  • diabetes (no effect on LDL / HDL cholesterol, and carbohydrate metabolism)
  • renal failure

stanozolol oral